Immunotherapy of multiple sclerosis: where are we? Where should we go?

Nat Immunol. 2001 Sep;2(9):785-8. doi: 10.1038/ni0901-785.
No abstract available

MeSH terms

  • Autoimmunity
  • Forecasting
  • Genetic Predisposition to Disease
  • Humans
  • Interferon-beta / therapeutic use
  • Models, Immunological*
  • Multiple Sclerosis / genetics
  • Multiple Sclerosis / immunology*
  • Multiple Sclerosis / therapy*
  • Self Tolerance
  • T-Lymphocytes / immunology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Tumor Necrosis Factor-alpha
  • Interferon-beta